NCT06963736Completed
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 5 (actual)
- First submitted
- 29 Apr 2025
- Start date
- 7 Aug 2025
- Primary completion date
- 9 Jul 2026
- Lead sponsor
- Arizona State University
- Diseases
- Obesity
- NCT number
- NCT06963736
What you commit to
- Study type: Interventional
- Participants enrolled: 5
- From 7 Aug 2025 to the primary completion date, 9 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug abuse
- Previous or current diagnosis of a clinical eating disorder (e.g., night eating syndrome, anorexia, bulimia, binge eating disorder); or self-report eating disorder behaviors
- Recent or upcoming jetlag (travel 3 months prior and during study that is \>1 time zone away from Arizona)
Other illness
- Conditions related to sleep disruption, including lactation, pregnancy, mid-night care providers, sleep disorders, severe sleep apnea
- History of hypoglycemia
- Chronic illness that may be associated with weight change (HIV/AIDS, active cancer, or uncontrolled thyroid disease)
- Poorly controlled hypertension (SBP ≥165 or DBP ≥100)
- Any condition or circumstance that would prevent compliance to the protocol
Lab values
- Medications that markedly impact glucose metabolism and sleep (insulin, corticosteroids, growth hormone, melatonin)
- Unstable or poorly controlled blood glucose (e.g., hypoglycemia, fasting glucose greater than 125 mg/dL)
Other
- Pacemaker
- Caffeine consumption in excess and/or after 5pm (excess equals \>4 cups of coffee per day or equivalent)
- Involvement in other physical activity, diet, or weight loss programs/studies
- Weight change of 5% up or down in the last three months.
- THC use (smoking, edibles)
- Excessive alcohol use (for women, 8 or more drinks per week; for men, 15 or more drinks per week)
- Current smoker or user of any nicotine source - any amount or form (vapor/e-cig/tobacco/patch, gum, etc.)
- Shift work
- Current practice of evening and nighttime blue light blocking.
- Use non-android phone as their primary/personal phone
Who the study is looking for
- ≥26 years of age
- BMI ≥ 27 kg/m2\*; ≥25 kg/m2, if Asian (full or multiple race)\*\*
- Insufficiently active (per US National Guidelines for Physical Activity of 150 minutes of MVPA/Week)
- Reporting an average of ≥3 hours of recreational sedentary screen time (rSST) per day, that usually extends at least until 9:00pm.
- On a typical night, consumes calories (food and/or drink) after 8:00pm.
- Meet at least 2 criteria for metabolic syndrome
- Central adiposity: waist circumference \>40 inches (men); \>35 inches (women)
- Elevated blood pressure: SBP \>130 mmHg and/or DBP \>85 mmHg OR controlled with medication
- Low high density lipoprotein (HDL) cholesterol: \<40 mg/dL (men); \<50 mg/dL (women)
- Elevated triglycerides: \>150 mg/dL OR controlled with medication
- Elevated fasting glucose: ≥100 mg/dL OR controlled with medication
Age in the registry: 26 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Arizona State University Coordinator of this site? Confirm its status | Tempe | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.